The FDA approved nemolizumab (Nemluvio) in combination with prescription topical agents for the treatment of ...

AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...

Pfizer has gained FDA approval for Eucrisa, a new eczema treatment which could achieve peak annual sales of $2 billion a year. The drug is significant because it is the first non-steroidal therapy ...

For some people, keeping up with eczema treatments can be difficult, but resources are available to help find relief from the ...

The clinical trial is for a new drug for people with moderate to severe eczema, the NHS trust says The first UK patient has been recruited to take part in a clinical trial for a new drug for ...

Skin experts are to test a new cream for the treatment of eczema after trials of an oral version of the drug reduced patients’ symptoms by 35% within a month. University of Manchester researchers in ...

At the age of four, Joel Godfrey's eczema was wreaking ... Joel's life has been transformed by a new ointment called tacrolimus which is based on an anti-rejection drug used in transplants.

Health Minister Mark Butler has struck a deal to secure the place of a “life-changing” eczema treatment on the Pharmaceutical ...

Nonspecific anti-inflammatories like steroids might be entirely sidelined for mild-to-moderate chronic hand eczema now that three targeted topical agents are available.